DE69836197D1 - Methylierte smd homologe peptide, die mit antikörpern aus sera von lebewesen mit systemischer lupus erythematodes reagieren - Google Patents

Methylierte smd homologe peptide, die mit antikörpern aus sera von lebewesen mit systemischer lupus erythematodes reagieren

Info

Publication number
DE69836197D1
DE69836197D1 DE69836197T DE69836197T DE69836197D1 DE 69836197 D1 DE69836197 D1 DE 69836197D1 DE 69836197 T DE69836197 T DE 69836197T DE 69836197 T DE69836197 T DE 69836197T DE 69836197 D1 DE69836197 D1 DE 69836197D1
Authority
DE
Germany
Prior art keywords
antibodies
systemic lupus
sera
smd
methylated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69836197T
Other languages
English (en)
Other versions
DE69836197T2 (de
Inventor
Lydie Meheus
Georg Luehrmann
Ann Union
Joseph Raymackers
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujirebio Europe NV SA
Original Assignee
Innogenetics NV SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Innogenetics NV SA filed Critical Innogenetics NV SA
Application granted granted Critical
Publication of DE69836197D1 publication Critical patent/DE69836197D1/de
Publication of DE69836197T2 publication Critical patent/DE69836197T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/001—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4713—Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/525—Tumour necrosis factor [TNF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Rheumatology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Rehabilitation Therapy (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE69836197T 1997-08-29 1998-08-31 Methylierte smd homologe peptide, die mit antikörpern aus sera von lebewesen mit systemischer lupus erythematodes reagieren Expired - Lifetime DE69836197T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP97870127 1997-08-29
EP97870127 1997-08-29
PCT/EP1998/005518 WO1999011667A1 (en) 1997-08-29 1998-08-31 METHYLATED, SmD HOMOLOGOUS PEPTIDES, REACTIVE WITH THE ANTIBODIES FROM SERA OF LIVING BEINGS AFFECTED WITH SYSTEMIC LUPUS ERYTHEMATOSUS

Publications (2)

Publication Number Publication Date
DE69836197D1 true DE69836197D1 (de) 2006-11-30
DE69836197T2 DE69836197T2 (de) 2007-09-06

Family

ID=8231033

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69836197T Expired - Lifetime DE69836197T2 (de) 1997-08-29 1998-08-31 Methylierte smd homologe peptide, die mit antikörpern aus sera von lebewesen mit systemischer lupus erythematodes reagieren

Country Status (9)

Country Link
US (2) US6362007B1 (de)
EP (1) EP0944649B1 (de)
JP (1) JP2001505785A (de)
AT (1) ATE342920T1 (de)
AU (1) AU751784B2 (de)
CA (1) CA2270176C (de)
DE (1) DE69836197T2 (de)
ES (1) ES2276474T3 (de)
WO (1) WO1999011667A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020002270A1 (en) * 1999-06-16 2002-01-03 Raymond P. Zinkowski Purified antigen for alzheimer's disease, and methods of obtaining and using same
AU2452301A (en) 1999-12-22 2001-07-03 Research Foundation Of The State University Of New York, The Protein methylarginine-specific antibodies
EP1162274A1 (de) * 2000-06-09 2001-12-12 Boehringer Ingelheim International GmbH Verfahren zur Identifizierung von Verbindungen, die die Methyltransferase-abhängige Chromosomen-Stabilität beeinflussen
EP1162460A1 (de) * 2000-06-09 2001-12-12 Boehringer Ingelheim International GmbH Screeningverfahren für Modulatoren des Suv39h2 Methyltransferases und der männlichen Gametogenese
DE60115039T2 (de) * 2000-06-09 2006-07-27 Boehringer Ingelheim International Gmbh Screeningverfahren für modulatoren von methyltransferase abhängiger chromosomenstabilität
EP1311549A2 (de) 2000-08-22 2003-05-21 Micromet AG Zusammensetzung zur eliminierung autoreaktiver b-zellen
SE0300958D0 (sv) * 2003-04-02 2003-04-02 Pharmacia Diagnostics Ab Analytical method and kit therof
JPWO2005075414A1 (ja) * 2004-02-04 2007-10-11 公立大学法人横浜市立大学 ペプチジルアルギニンデイミナーゼ４阻害剤
US7422696B2 (en) * 2004-02-20 2008-09-09 Northwestern University Multicomponent nanorods
US20050277205A1 (en) * 2004-02-20 2005-12-15 Ki-Bum Lee Multicomponent magnetic nanorods for biomolecular separations
US8852870B2 (en) * 2008-06-16 2014-10-07 University Of Louisville Research Foundation, Inc. Systems and methods for diagnosis and prognosis of cancer
US10295547B2 (en) 2013-03-14 2019-05-21 University Of Florida Research Foundation, Incorporated Use and treatment of di-amino acid repeat-containing proteins associated with ALS
CA3019847A1 (en) 2016-04-04 2017-10-12 University Of Florida Research Foundation, Incorporated Manipulation of eif3 to modulate repeat associated non-atg (ran) translation
CN106188272A (zh) * 2016-07-27 2016-12-07 朱玫玫 基因工程鼠提高Btg2表达水平的新功能
JP7526455B2 (ja) 2017-04-17 2024-08-01 ユニバーシティー オブ フロリダ リサーチ ファンデーション， インク． ＰＫＲおよびｅＩＦ２Ａ－Ｐ経路によるＲＡＮタンパク質翻訳の調節
CA3076214A1 (en) 2017-09-26 2019-04-04 University Of Florida Research Foundation, Incorporated Use of metformin and analogs thereof to reduce ran protein levels in the treatment of neurological disorders

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4654419A (en) 1984-08-08 1987-03-31 Scripps Clinic And Research Foundation Synthetic polypeptides and antibodies related to epstein-barr virus nuclear antigen
FR2663034B1 (fr) 1990-06-06 1995-04-21 Neosystem Sa Peptides de l'antigene sm-d et leur utilisation notamment pour le diagnostic du lupus erythemateux dissemine.
AU1209995A (en) * 1993-11-17 1995-06-06 Duke University Medical Center Use of nitric oxide synthase inhibitors in the treatment of autoimmune diseases
EP0776906A3 (de) * 1995-10-19 1998-02-25 Imtec Immundiagnostika Gmbh Peptide des Antigens Sm-D und ihre Verwendung, insbesondere für die Diagnostik des SLE

Also Published As

Publication number Publication date
CA2270176C (en) 2011-08-23
ES2276474T3 (es) 2007-06-16
JP2001505785A (ja) 2001-05-08
ATE342920T1 (de) 2006-11-15
AU751784B2 (en) 2002-08-29
AU9438798A (en) 1999-03-22
EP0944649B1 (de) 2006-10-18
DE69836197T2 (de) 2007-09-06
US20020165355A1 (en) 2002-11-07
WO1999011667A1 (en) 1999-03-11
CA2270176A1 (en) 1999-03-11
US6362007B1 (en) 2002-03-26
EP0944649A1 (de) 1999-09-29

Similar Documents

Publication Publication Date Title
DE69836197D1 (de) Methylierte smd homologe peptide, die mit antikörpern aus sera von lebewesen mit systemischer lupus erythematodes reagieren
EP2258383A3 (de) Von der Telomerase abgeleitete antigene Peptide
WO2001039796A3 (en) Vaccine for the prevention and treatment of alzheimer's and amyloid related diseases
ATE267211T1 (de) Impfstoff gegen hpv
DE69634726D1 (de) Menschliche ctla-8 und verwendung von ctla-8 ähnlichen proteinen
ATE194291T1 (de) Neutralisierende monoklonale antikörper gegen respiratorischen synzytialvirus
ATE326479T1 (de) Varianten von antigenen des menschlichen papillomvirus
ATE376559T1 (de) Methoden der verhinderung und behandlung der alzheimer'schen krankheit
ATE294864T1 (de) Äusseres membranprotein von haemophilus
ATE144143T1 (de) Künstlicher impfstoff gegen aids-virus
EP0269455A3 (de) Hochgereinigtes Fusionsprotein, das ein menschliches IgE Fc-Fragment enthält, sowie dessen Herstellung
DE3685651D1 (de) Den antigenischen und immunogenischen determinanten von wichtigen neutralisierenden proteinen des rotavirus entsprechende peptide.
DE69508382D1 (de) Peptomere mit erhöhter immunogenizität
AU612683B2 (en) Synthetic peptides, antibodies directed against them, and the use thereof
ATE201693T1 (de) Hämoregulierende peptide
NO20005081D0 (no) Et polypeptid inneholdende aminosyren fra et N-terminalt kolinbindende protein A-truncat, vaksine avledet derfra og anvendelser derav
DE69329347D1 (de) Immunreaktive peptide des epstein-barrvirus
DE69840628D1 (de) Nicht-anaphylaktische allergenarten und ihre verwendung
ATE346091T1 (de) Neues diagnostisches reagens und kit zur erkennung von rickettsiose
NZ508812A (en) Peptides for the prevention or treatment of HIV
ATE452903T1 (de) Modifizierte peptide und deren verwendung zur behandlung von autoimmunkrankheiten
DE69328488D1 (de) Peptide, analoge und ihre mischungen zur detektion und erzeugung von antikörpern gegen die e1 und e2 proteine des rubella virus
NO982151D0 (no) Hemoregulatoriske forbindelser
ATE512981T1 (de) Identifizierung von ses-3 (spr-5) aus c. elegans sowie dessen verwendungen
TH23725A (th) วัคซีนป้องกันโรคบิดสำหรับสัตว์ปีก

Legal Events

Date Code Title Description
8364 No opposition during term of opposition